Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.

Workman DG, Hunter M, Wang S, Brandel J, Hubscher V, Dover LG, Tétard D.

Bioorg Chem. 2019 Dec 2;95:103465. doi: 10.1016/j.bioorg.2019.103465. [Epub ahead of print]

PMID:
31855824
2.

Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.

Schwartz M, Brandel JP, Babonneau ML, Boucher C, Schaerer E, Haik S, Laplanche JL, Gargiulo M, Durr A.

Front Genet. 2019 Sep 20;10:895. doi: 10.3389/fgene.2019.00895. eCollection 2019.

3.

Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.

Lee PC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Brice A, Vidailhet M, Corvol JC, Elbaz A; DIGPD Study Group.

Mov Disord. 2019 Nov;34(11):1663-1671. doi: 10.1002/mds.27854. Epub 2019 Sep 13.

PMID:
31518456
4.

Factors influencing the incubation of an infectious form of Creutzfeldt-Jakob disease.

Peckeu L, Brandel JP, Welaratne A, Amar E, Costagliola D, Haïk S.

Clin Infect Dis. 2019 Jul 28. pii: ciz692. doi: 10.1093/cid/ciz692. [Epub ahead of print]

PMID:
31351441
5.

Amplification techniques and diagnosis of prion diseases.

Brandel JP, Culeux A, Grznarova K, Levavasseur E, Lamy P, Privat N, Welaratne A, Denouel A, Laplanche JL, Haik S.

Rev Neurol (Paris). 2019 Sep - Oct;175(7-8):458-463. doi: 10.1016/j.neurol.2019.06.002. Epub 2019 Jul 8. Review.

PMID:
31296398
6.

Age at onset in genetic prion disease and the design of preventive clinical trials.

Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, Knipper T, Stehmann C, Kitamoto T, Ae R, Hamaguchi T, Sanjo N, Tsukamoto T, Mizusawa H, Collins SJ, Chiesa R, Roiter I, de Pedro-Cuesta J, Calero M, Geschwind MD, Yamada M, Nakamura Y, Mead S.

Neurology. 2019 Jul 9;93(2):e125-e134. doi: 10.1212/WNL.0000000000007745. Epub 2019 Jun 6.

PMID:
31171647
7.

Tonic spinal cord stimulation as therapeutic option in Parkinson disease with axial symptoms: Effects on walking and quality of life.

Hubsch C, D'Hardemare V, Ben Maacha M, Ziegler M, Patte-Karsenti N, Thiebaut JB, Gout O, Brandel JP.

Parkinsonism Relat Disord. 2019 Jun;63:235-237. doi: 10.1016/j.parkreldis.2019.02.044. Epub 2019 Mar 2.

PMID:
30852148
8.

First European case of Creutzfeldt-Jakob disease with a PRNP G114V mutation.

Cousyn L, Grabli D, Seilhean D, Azuar C, Huiban C, Epelbaum S, Bouaziz-Amar E, Brandel JP, Galanaud D, Méneret A.

Cortex. 2019 Aug;117:407-413. doi: 10.1016/j.cortex.2018.08.014. Epub 2018 Sep 1.

PMID:
30266397
9.

Susceptibility to Creutzfeldt-Jakob disease after human growth hormone treatment in France.

Peckeu L, Brandel JP, Welaratne A, Costagliola D, Haïk S.

Neurology. 2018 Aug 21;91(8):e724-e731. doi: 10.1212/WNL.0000000000006028. Epub 2018 Jul 25.

PMID:
30045957
10.

Longitudinal analysis of impulse control disorders in Parkinson disease.

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group.

Neurology. 2018 Jul 17;91(3):e189-e201. doi: 10.1212/WNL.0000000000005816. Epub 2018 Jun 20.

11.

Variant Creutzfeldt-Jakob disease.

Brandel JP, Knight R.

Handb Clin Neurol. 2018;153:191-205. doi: 10.1016/B978-0-444-63945-5.00011-8.

PMID:
29887136
12.

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.

Cali I, Cohen ML, Haik S, Parchi P, Giaccone G, Collins SJ, Kofskey D, Wang H, McLean CA, Brandel JP, Privat N, Sazdovitch V, Duyckaerts C, Kitamoto T, Belay ED, Maddox RA, Tagliavini F, Pocchiari M, Leschek E, Appleby BS, Safar JG, Schonberger LB, Gambetti P.

Acta Neuropathol Commun. 2018 Jan 8;6(1):5. doi: 10.1186/s40478-017-0503-z.

13.

Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.

Duyckaerts C, Sazdovitch V, Ando K, Seilhean D, Privat N, Yilmaz Z, Peckeu L, Amar E, Comoy E, Maceski A, Lehmann S, Brion JP, Brandel JP, Haïk S.

Acta Neuropathol. 2018 Feb;135(2):201-212. doi: 10.1007/s00401-017-1791-x. Epub 2017 Nov 22.

PMID:
29209767
14.

Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009.

Peckeu L, Delasnerie-Lauprètre N, Brandel JP, Salomon D, Sazdovitch V, Laplanche JL, Duyckaerts C, Seilhean D, Haïk S, Hauw JJ.

Euro Surveill. 2017 Oct;22(41). doi: 10.2807/1560-7917.ES.2017.22.41.16-00715.

15.

Sequential Delivery of Doxorubicin and Zoledronic Acid to Breast Cancer Cells by CB[7]-Modified Iron Oxide Nanoparticles.

Benyettou F, Alhashimi M, O'Connor M, Pasricha R, Brandel J, Traboulsi H, Mazher J, Olsen JC, Trabolsi A.

ACS Appl Mater Interfaces. 2017 Nov 22;9(46):40006-40016. doi: 10.1021/acsami.7b11423. Epub 2017 Nov 7.

PMID:
29035507
16.

A Bispidol Chelator with a Phosphonate Pendant Arm: Synthesis, Cu(II) Complexation, and 64Cu Labeling.

Gillet R, Roux A, Brandel J, Huclier-Markai S, Camerel F, Jeannin O, Nonat AM, Charbonnière LJ.

Inorg Chem. 2017 Oct 2;56(19):11738-11752. doi: 10.1021/acs.inorgchem.7b01731. Epub 2017 Sep 15.

17.

Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.

Privat N, Levavasseur E, Yildirim S, Hannaoui S, Brandel JP, Laplanche JL, Béringue V, Seilhean D, Haïk S.

J Biol Chem. 2017 Oct 6;292(40):16688-16696. doi: 10.1074/jbc.M117.793646. Epub 2017 Aug 15.

18.

Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease.

Bougard D, Brandel JP, Bélondrade M, Béringue V, Segarra C, Fleury H, Laplanche JL, Mayran C, Nicot S, Green A, Welaratne A, Narbey D, Fournier-Wirth C, Knight R, Will R, Tiberghien P, Haïk S, Coste J.

Sci Transl Med. 2016 Dec 21;8(370):370ra182. doi: 10.1126/scitranslmed.aag1257.

PMID:
28003547
19.

Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man.

Saint-Aubert L, Pariente J, Dumas H, Payoux P, Brandel JP, Puel M, Vital A, Guedj E, Lesage S, Peoc'h K, Brefel Courbon C, Ory Magne F.

BMC Neurol. 2016 Jul 30;16:122. doi: 10.1186/s12883-016-0643-y.

20.

Quantifying prion disease penetrance using large population control cohorts.

Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, McLean CY, Tung JY, Yu LP, Gambetti P, Blevins J, Zhang S, Cohen Y, Chen W, Yamada M, Hamaguchi T, Sanjo N, Mizusawa H, Nakamura Y, Kitamoto T, Collins SJ, Boyd A, Will RG, Knight R, Ponto C, Zerr I, Kraus TF, Eigenbrod S, Giese A, Calero M, de Pedro-Cuesta J, Haïk S, Laplanche JL, Bouaziz-Amar E, Brandel JP, Capellari S, Parchi P, Poleggi A, Ladogana A, O'Donnell-Luria AH, Karczewski KJ, Marshall JL, Boehnke M, Laakso M, Mohlke KL, Kähler A, Chambert K, McCarroll S, Sullivan PF, Hultman CM, Purcell SM, Sklar P, van der Lee SJ, Rozemuller A, Jansen C, Hofman A, Kraaij R, van Rooij JG, Ikram MA, Uitterlinden AG, van Duijn CM; Exome Aggregation Consortium (ExAC), Daly MJ, MacArthur DG.

Sci Transl Med. 2016 Jan 20;8(322):322ra9. doi: 10.1126/scitranslmed.aad5169.

21.

[Is Parkinson's disease a prion disease?].

Brandel JP, Corbillé AG, Derkinderen P, Haïk S.

Rev Neurol (Paris). 2015 Dec;171(12):812-24. doi: 10.1016/j.neurol.2015.10.005. Epub 2015 Nov 10. Review. French.

PMID:
26563663
22.

Does HIV Infection Alter Parkinson Disease?

Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C.

J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):129-36. doi: 10.1097/QAI.0000000000000677.

PMID:
26371610
23.

History of Prions and transmission of protein misfolding.

Hauw JJ, Haik S, Brandel JP.

Bull Acad Natl Med. 2015 Jun;199(6):787-796.

PMID:
29901879
24.

A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.

Sanchez-Juan P, Bishop MT, Kovacs GG, Calero M, Aulchenko YS, Ladogana A, Boyd A, Lewis V, Ponto C, Calero O, Poleggi A, Carracedo Á, van der Lee SJ, Ströbel T, Rivadeneira F, Hofman A, Haïk S, Combarros O, Berciano J, Uitterlinden AG, Collins SJ, Budka H, Brandel JP, Laplanche JL, Pocchiari M, Zerr I, Knight RS, Will RG, van Duijn CM.

PLoS One. 2015 Apr 28;10(4):e0123654. doi: 10.1371/journal.pone.0123654. eCollection 2014.

25.

Kinetically Inert Bispidol-Based Cu(II) Chelate for Potential Application to (64/67)Cu Nuclear Medicine and Diagnosis.

Roux A, Nonat AM, Brandel J, Hubscher-Bruder V, Charbonnière LJ.

Inorg Chem. 2015 May 4;54(9):4431-44. doi: 10.1021/acs.inorgchem.5b00207. Epub 2015 Apr 13.

PMID:
25866934
26.

Prions in the urine of patients with variant Creutzfeldt-Jakob disease.

Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park KW, Maderna E, Suardi S, Haïk S, Brandel JP, Ironside J, Knight R, Tagliavini F, Soto C.

N Engl J Med. 2014 Aug 7;371(6):530-9. doi: 10.1056/NEJMoa1404401.

27.

Infectious prion diseases in humans: cannibalism, iatrogenicity and zoonoses.

Haïk S, Brandel JP.

Infect Genet Evol. 2014 Aug;26:303-12. doi: 10.1016/j.meegid.2014.06.010. Epub 2014 Jun 20. Review.

PMID:
24956437
28.

Tetraphosphonated thiophene ligand: mixing the soft and the hard.

Brandel J, Lecointre A, Kollek J, Michel S, Hubscher-Bruder V, Déchamps-Olivier I, Platas-Iglesias C, Charbonnière LJ.

Dalton Trans. 2014 Jun 28;43(24):9070-80. doi: 10.1039/c4dt00451e.

PMID:
24788186
29.

Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.

Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, Azimi S, Pietrini V, Fabreguettes JR, Imperiale D, Cesaro P, Buffa C, Aucan C, Lucca U, Peckeu L, Suardi S, Tranchant C, Zerr I, Houillier C, Redaelli V, Vespignani H, Campanella A, Sellal F, Krasnianski A, Seilhean D, Heinemann U, Sedel F, Canovi M, Gobbi M, Di Fede G, Laplanche JL, Pocchiari M, Salmona M, Forloni G, Brandel JP, Tagliavini F.

Lancet Neurol. 2014 Feb;13(2):150-8. doi: 10.1016/S1474-4422(13)70307-7. Epub 2014 Jan 8.

PMID:
24411709
30.

Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific.

Hannaoui S, Gougerot A, Privat N, Levavasseur E, Bizat N, Hauw JJ, Brandel JP, Haïk S.

J Infect Dis. 2014 Apr 1;209(7):1144-8. doi: 10.1093/infdis/jit623. Epub 2013 Nov 21.

PMID:
24265435
31.

Intensity of human prion disease surveillance predicts observed disease incidence.

Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, Matěj R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, Brandel JP, Alperovitch A, Budka H, Kovacs GG, Jansen GH, Coulthard M, Collins SJ.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1372-7. doi: 10.1136/jnnp-2012-304820. Epub 2013 Aug 21.

PMID:
23965290
32.

The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.

Brandel JP, Peckeu L, Haïk S.

Transfus Clin Biol. 2013 Sep;20(4):395-7. doi: 10.1016/j.tracli.2013.02.029. Epub 2013 Apr 12. Review.

PMID:
23587616
33.

Glycoform-selective prion formation in sporadic and familial forms of prion disease.

Xiao X, Yuan J, Haïk S, Cali I, Zhan Y, Moudjou M, Li B, Laplanche JL, Laude H, Langeveld J, Gambetti P, Kitamoto T, Kong Q, Brandel JP, Cobb BA, Petersen RB, Zou WQ.

PLoS One. 2013;8(3):e58786. doi: 10.1371/journal.pone.0058786. Epub 2013 Mar 19.

34.

Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries.

Diack AB, Ritchie D, Bishop M, Pinion V, Brandel JP, Haik S, Tagliavini F, Van Duijn C, Belay ED, Gambetti P, Schonberger LB, Piccardo P, Will RG, Manson JC.

Emerg Infect Dis. 2012 Oct;18(10):1574-9. doi: 10.3201/eid1810.120792.

35.

Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.

Peoc'h K, Levavasseur E, Delmont E, De Simone A, Laffont-Proust I, Privat N, Chebaro Y, Chapuis C, Bedoucha P, Brandel JP, Laquerriere A, Kemeny JL, Hauw JJ, Borg M, Rezaei H, Derreumaux P, Laplanche JL, Haïk S.

Hum Mol Genet. 2012 Dec 15;21(26):5417-28. doi: 10.1093/hmg/dds377. Epub 2012 Sep 10. Erratum in: Hum Mol Genet. 2014 Apr 15;23(8):2234.

PMID:
22965875
36.

Iatrogenic Creutzfeldt-Jakob disease, final assessment.

Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB.

Emerg Infect Dis. 2012 Jun;18(6):901-7. doi: 10.3201/eid1806.120116.

37.

Glycosiderophores: synthesis of tris-hydroxamate siderophores based on a galactose or glycero central scaffold, Fe(III) complexation studies.

Neff C, Bellot F, Waern JB, Lambert F, Brandel J, Serratrice G, Gaboriau F, Policar C.

J Inorg Biochem. 2012 Jul;112:59-67. doi: 10.1016/j.jinorgbio.2012.02.030. Epub 2012 Mar 7.

PMID:
22551986
38.

Health professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010.

Alcalde-Cabero E, Almazan-Isla J, Brandel JP, Breithaupt M, Catarino J, Collins S, Hayback J, Hoftberger R, Kahana E, Kovacs GG, Ladogana A, Mitrova E, Molesworth A, Nakamura Y, Pocchiari M, Popovic M, Ruiz-Tovar M, Taratuto A, van Duijn C, Yamada M, Will RG, Zerr I, de Pedro Cuesta J.

Euro Surveill. 2012 Apr 12;17(15). pii: 20144. Review.

39.

Rapidly progressive Alzheimer's disease: a multicenter update.

Schmidt C, Haïk S, Satoh K, Rábano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I.

J Alzheimers Dis. 2012;30(4):751-6. doi: 10.3233/JAD-2012-120007.

PMID:
22460329
40.

Pyochelin, a siderophore of Pseudomonas aeruginosa: physicochemical characterization of the iron(III), copper(II) and zinc(II) complexes.

Brandel J, Humbert N, Elhabiri M, Schalk IJ, Mislin GL, Albrecht-Gary AM.

Dalton Trans. 2012 Mar 7;41(9):2820-34. doi: 10.1039/c1dt11804h. Epub 2012 Jan 20.

PMID:
22261733
41.

Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk.

Sanchez-Juan P, Bishop MT, Aulchenko YS, Brandel JP, Rivadeneira F, Struchalin M, Lambert JC, Amouyel P, Combarros O, Sainz J, Carracedo A, Uitterlinden AG, Hofman A, Zerr I, Kretzschmar HA, Laplanche JL, Knight RS, Will RG, van Duijn CM.

Neurobiol Aging. 2012 Jul;33(7):1487.e21-8. doi: 10.1016/j.neurobiolaging.2011.10.011. Epub 2011 Dec 2.

PMID:
22137330
42.

Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study.

Pillonel J, Brandel JP, Léon L, Salomon D, Haïk S, Capek I, Vaillant V, Coste J, Alpérovitch A.

Transfusion. 2012 Jun;52(6):1290-5. doi: 10.1111/j.1537-2995.2011.03459.x. Epub 2011 Dec 1.

PMID:
22128904
43.

Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008.

Brandel JP, Welaratne A, Salomon D, Capek I, Vaillant V, Aouba A, Haïk S, Alpérovitch A.

Neuroepidemiology. 2011;37(3-4):188-92. doi: 10.1159/000332764. Epub 2011 Nov 2. Erratum in: Neuroepidemiology. 2012;38(3):193. Aouaba, Albertine [corrected to Aouba, Albertine].

PMID:
22057088
44.

Long-standing prion dementia manifesting as posterior cortical atrophy.

Depaz R, Haik S, Peoc'h K, Seilhean D, Grabli D, Vicart S, Sarazin M, DeToffol B, Remy C, Fallet-Bianco C, Laplanche JL, Fontaine B, Brandel JP.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):289-92.

PMID:
21959360
45.

Concurrent and construct validity of oral language measures with school-age children with specific language impairment.

Hoffman LM, Loeb DF, Brandel J, Gillam RB.

J Speech Lang Hear Res. 2011 Dec;54(6):1597-608. doi: 10.1044/1092-4388(2011/10-0213). Epub 2011 Sep 19.

46.

Biochemical and strain properties of CJD prions: complexity versus simplicity.

Haïk S, Brandel JP.

J Neurochem. 2011 Oct;119(2):251-61. doi: 10.1111/j.1471-4159.2011.07399.x. Epub 2011 Sep 20. Review.

47.

Unusual dopaminergic depletion in variant Creutzfeldt-Jakob disease with early and rapid cognitive decline.

Magnin E, Chopard G, Galmiche J, Brandel JP, Rumbach L.

Eur Neurol. 2011;65(6):368. doi: 10.1159/000328670. Epub 2011 May 31. No abstract available.

PMID:
21625143
48.

Program intensity and service delivery models in the schools: SLP survey results.

Brandel J, Frome Loeb D.

Lang Speech Hear Serv Sch. 2011 Oct;42(4):461-90. doi: 10.1044/0161-1461(2011/10-0019). Epub 2011 May 26.

PMID:
21616986
49.

Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.

Faucheux BA, Morain E, Diouron V, Brandel JP, Salomon D, Sazdovitch V, Privat N, Laplanche JL, Hauw JJ, Haïk S.

Neuropathol Appl Neurobiol. 2011 Aug;37(5):500-12. doi: 10.1111/j.1365-2990.2011.01179.x.

PMID:
21450052
50.

Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?

Boyd A, Klug GM, Schonberger LB, McGlade A, Brandel JP, Masters CL, Collins SJ.

Med J Aust. 2010 Sep 20;193(6):366-9.

PMID:
20854243

Supplemental Content

Loading ...
Support Center